C.M. Bidwell & Associates’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,220
Closed -$241K 553
2024
Q2
$241K Sell
2,220
-12
-0.5% -$1.42K 0.16% 105
2024
Q1
$295K Buy
2,232
+388
+21% +$48.5K 0.2% 90
2023
Q4
$224K Sell
1,844
-695
-27% -$77.5K 0.17% 107
2023
Q3
$285K Buy
2,539
+1,796
+242% +$228K 0.22% 78
2023
Q2
$108K Buy
+743
New +$101K 0.08% 225
2022
Q4
Sell
-782
Closed -$82K 541
2022
Q3
$82K Hold
782
0.07% 239
2022
Q2
$82K Buy
+782
New +$92.8K 0.06% 240
2020
Q1
Sell
-1,092
Closed -$159K 478
2019
Q4
$159K Sell
1,092
-36
-3% -$4.97K 0.14% 131
2019
Q3
$150K Buy
+1,128
New +$146K 0.15% 156
2017
Q4
Sell
-15
Closed -$2K 457
2017
Q3
$2K Hold
15
﹤0.01% 282
2017
Q2
$2K Buy
+15
New +$1.78K ﹤0.01% 298
2016
Q4
Sell
-32,085
Closed -$4.05M 322
2016
Q3
$4.05M Buy
32,085
+25,251
+369% +$3.12M 0.97% 38
2016
Q2
$799K Buy
6,834
+1,246
+22% +$141K 0.2% 91
2016
Q1
$578K Buy
+5,588
New +$541K 0.14% 99
2014
Q1
Sell
-2,879
Closed -$260K 270
2013
Q4
$260K Sell
2,879
-82
-3% -$7.1K 0.06% 126
2013
Q3
$236K Hold
2,961
0.06% 132
2013
Q2
$215K Buy
+2,961
New +$221K 0.06% 119

Other funds holding ZBH

C.M. Bidwell & Associates's ZBH Position: Q3 2024 in Review

C.M. Bidwell & Associates sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,220 shares — an estimated $241K sold.

C.M. Bidwell & Associates first reported a position in ZBH in Q2 2013 and held it in 17 quarters. The position peaked at $4.05M in Q3 2016. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • C.M. Bidwell & Associates reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,220 Zimmer Biomet shares in Q3 2024, an estimated $241K.
  • C.M. Bidwell & Associates first reported a position in Zimmer Biomet in Q2 2013 and held it in 17 quarters.
  • C.M. Bidwell & Associates's Zimmer Biomet position peaked at $4.05M in Q3 2016.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.